The Mylan Advocate® Co-Pay Assistance Program for Mylan’s OgivriTM (trastuzumab-dkst) for injection 150 mg/vial and/or 420 mg/vials open to both new and existing eligible patients who have commercial prescription drug insurance.
This co-pay assistance can be redeemed by patients or patient guardians who are residents of the U.S. or Puerto Rico and who are 18 years of age or older, subject to the full terms and conditions set forth on Mylan’s website as it may be updated from time to time - www.mylanadvocate.com. This co-pay assistance program can be used to reduce the amount of an eligible patient’s out-of-pocket expenses for Mylan’s OgivriTM (trastuzumab-dkst) for injection 150 mg/vial and/or 420 mg/vial up to the maximum aggregate amount set forth on Mylan’s website while this co-pay assistance program remains in effect (such aggregate amount includes dispenses of both OgivriTM (trastuzumab-dkst) for injection 150 mg/vial and 420 mg/vial).
This co-pay assistance program is not valid for uninsured patients or commercially insured patients without coverage for OgivriTM (trastuzumab-dkst) for injection 150 mg/vial and/or 420 mg/vial; not valid for patients who are covered in whole or in part by any state or federally funded healthcare program, including, but not limited to, any state pharmaceutical assistance program, Medicare (Part D or otherwise), Medicaid, Medigap, VA or DOD, or TriCare (regardless of whether OgivriTM (trastuzumab-dkst) for injection 150 mg/vial and/or 420 mg/vial is covered by such government program); not valid if the patient is Medicare eligible and enrolled in an employer-sponsored health plan or prescription beneﬁt program for retirees; and not valid if the patient’s insurance plan is paying the entire cost of this prescription. This co-pay assistance program is void outside the U.S. or Puerto Rico or in any state or jurisdiction where prohibited by law, taxed or restricted. Absent a change in Massachusetts law, this co-pay assistance program will no longer be valid for Massachusetts residents as of January 1, 2020. Please see Mylan’s website for any updates.
Valid prescription required. Use of this co-pay assistance program must be consistent with the terms of any drug beneﬁt provided by a commercial health insurer, health plan or private third-party payer. This co-pay assistance program may be changed or discontinued at any time without notice. This co-pay assistance program is not health insurance. The co-pay assistance program is not transferable, and the amount of the savings cannot exceed the patient’s out-of-pocket expenses. Cannot be combined with any other rebate/coupon, free trial, or similar offer for the speciﬁed prescription. The co-pay assistance is not redeemable for cash. No additional purchase is required. Data related to your use of this co-pay assistance program may be collected, analyzed and shared with Mylan for market research and other purposes related to assessing copay assistance programs. Data shared with Mylan will be aggregated and de-identiﬁed, meaning it will be combined with data related to other co-pay assistance program redemptions and will not identify you.